| scholarly article | Q13442814 |
| P2093 | author name string | D A Taylor | |
| D T Malone | |||
| P2860 | cites work | Cannabinoid receptor localization in brain | Q24558751 |
| 5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine | Q34245467 | ||
| Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 | ||
| Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis | Q34631075 | ||
| Modulation of delta9-tetrahydrocannabinol-induced hypothermia by fluoxetine in the rat | Q35027871 | ||
| Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder | Q35874137 | ||
| Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves | Q35874165 | ||
| Marijuana's interaction with brain reward systems: update 1991. | Q37028121 | ||
| ‘Antagonist’-precipitated withdrawal in the rat after chronic Δ9-tetrahydrocannabinol treatment | Q39219140 | ||
| Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man. | Q39502390 | ||
| Cannabinoid pharmacology | Q39741984 | ||
| Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors | Q42014580 | ||
| SR141716A is an inverse agonist at the human cannabinoid CB1 receptor | Q42445979 | ||
| Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT | Q42708046 | ||
| Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism | Q44346123 | ||
| Cocaine: an in vivo microdialysis evaluation of its acute action on dopamine transmission in rat striatum | Q44399077 | ||
| Facilitation of a dendritic calcium conductance by 5-hydroxytryptamine in the substantia nigra | Q46727226 | ||
| SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice | Q47628019 | ||
| Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids. | Q48225866 | ||
| Acute uptake inhibition increases extracellular serotonin in the rat forebrain | Q48281527 | ||
| Effects of delta9-tetrahydrocannabinol on neurotransmitter accumulation and release mechanisms in rat forebrain synaptosomes | Q48372902 | ||
| Effect of voltage-sensitive calcium channel antagonists on the release of 5-hydroxytryptamine from rat hippocampus in vivo | Q48447019 | ||
| Serotonin-stimulated release of [3H]dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: a comparison with release elicited by potassium, N-methyl-D-aspartic acid, glutamic acid and D-amphetamine | Q48464737 | ||
| Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum | Q48589813 | ||
| Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis | Q48686920 | ||
| Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus | Q48733768 | ||
| Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study | Q48788302 | ||
| The effect of Δ1-tetrahydrocannabinol on serotonin metabolism in the rat brain | Q48829242 | ||
| Delta 9-tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex | Q48859883 | ||
| Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum. | Q51745315 | ||
| Delta 9-tetrahydrocannabinol facilitates striatal dopaminergic transmission | Q69359129 | ||
| Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release | Q69696973 | ||
| The effects of delta 9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study | Q69853528 | ||
| Electrophysiological evidence for a functional differentiation between subtypes of the 5-HT1 receptor | Q69930102 | ||
| Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor antagonists | Q71293074 | ||
| Modulation of norepinephrine release by serotonergic receptors in the rat hippocampus as measured by in vivo microdialysis | Q72632948 | ||
| Endogenous serotonin stimulates striatal dopamine release in conscious rats | Q72731101 | ||
| Withdrawal-like behaviour induced by inhibitors of biogenic amine reuptake in rats treated chronically with ? 9-tetrahydrocannabinol | Q72857243 | ||
| The mechanism of action of ? 9 -tetrahydrocannabinol on body temperature in mice | Q72863695 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tetrahydrocannabinol | Q190067 |
| striatum | Q1319792 | ||
| fluoxetine | Q422244 | ||
| cannabinoids | Q422936 | ||
| P304 | page(s) | 21-26 | |
| P577 | publication date | 1999-09-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Modulation by fluoxetine of striatal dopamine release following Delta9-tetrahydrocannabinol: a microdialysis study in conscious rats | |
| P478 | volume | 128 |
| Q38036236 | A brain on cannabinoids: the role of dopamine release in reward seeking |
| Q39285753 | A focus on reward in anorexia nervosa through the lens of the activity-based anorexia (ABA) rodent model |
| Q35035878 | Addictive potential of cannabinoids: the underlying neurobiology |
| Q34545094 | Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats |
| Q24673420 | Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats |
| Q42154370 | Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine. |
| Q80762495 | Behavioural and neurochemical effects of combined MDMA and THC administration in mice |
| Q44619611 | Biphasic effects of cannabinoids on acetylcholine release in the hippocampus: site and mechanism of action. |
| Q34605794 | CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum |
| Q48470514 | Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats |
| Q35754854 | Cannabinoid modulation of cortical adrenergic receptors and transporters |
| Q41905626 | Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex |
| Q24628837 | Cannabis and psychosis/schizophrenia: human studies |
| Q36757474 | Cannabis cue-elicited craving and the reward neurocircuitry |
| Q46425083 | Chronic treatment and withdrawal of the cannabinoid agonist WIN 55,212-2 modulate the sensitivity of presynaptic receptors involved in the regulation of monoamine syntheses in rat brain |
| Q46406572 | Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum |
| Q44830723 | Differential effects of acute cannabinoid drug treatment, mediated by CB1 receptors, on the in vivo activity of tyrosine and tryptophan hydroxylase in the rat brain |
| Q45300313 | Differential effects of cannabinoid CB1 inverse agonists and antagonists on impulsivity in male Sprague Dawley rats: identification of a possibly clinically relevant vulnerability involving the serotonin 5HT1A receptor |
| Q43556006 | Effect of chronic and acute administration of fluoxetine and its additive effect with morphine on the behavioural response in the formalin test in rats |
| Q38250054 | Endocannabinoid-dependent modulation of phasic dopamine signaling encodes external and internal reward-predictive cues |
| Q36751811 | Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum |
| Q43235028 | Individual differences in the effects of cannabinoids on motor activity, dopaminergic activity and DARPP-32 phosphorylation in distinct regions of the brain |
| Q46384445 | Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis. |
| Q37512670 | Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy. |
| Q34639648 | Mitigation of post-traumatic stress symptoms by Cannabis resin: a review of the clinical and neurobiological evidence |
| Q34990029 | Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome |
| Q37132571 | Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2 |
| Q30417935 | Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine |
| Q40883182 | P2Y receptor-mediated inhibition of tumor necrosis factor alpha -stimulated stress-activated protein kinase activity in EAhy926 endothelial cells |
| Q37226537 | Prejunctional and peripheral effects of the cannabinoid CB(1) receptor inverse agonist rimonabant (SR 141716). |
| Q37529127 | Stress-induced sensitization of cortical adrenergic receptors following a history of cannabinoid exposure |
| Q36358712 | Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate |
| Q38891540 | The Role of Mesolimbic Reward Neurocircuitry in Prevention and Rescue of the Activity-Based Anorexia (ABA) Phenotype in Rats |
| Q45174910 | The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently |
| Q34988386 | The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia. |
| Q31143453 | The effects of cannabis use on salience attribution: a systematic review |
Search more.